Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fragment-based covalent ligand discovery
Wenchao Lu, Milka Kostić, Tinghu Zhang, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 2, pp. 354-367
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Advances in covalent drug discovery
Lydia Boike, Nathaniel J. Henning, Daniel K. Nomura
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 881-898
Open Access | Times Cited: 469
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 899-914
Open Access | Times Cited: 191
The Ascension of Targeted Covalent Inhibitors
Juswinder Singh
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 8, pp. 5886-5901
Closed Access | Times Cited: 126
Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 87
Fragment‐based drug discovery—the importance of high‐quality molecule libraries
Marta Bon, Alan Bilsland, Justin Bower, et al.
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3761-3777
Open Access | Times Cited: 75
Proteomic discovery of chemical probes that perturb protein complexes in human cells
Michael R. Lazear, Jarrett R. Remsberg, Martin G. Jaeger, et al.
Molecular Cell (2023) Vol. 83, Iss. 10, pp. 1725-1742.e12
Open Access | Times Cited: 65
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 44
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B. Chong, Siwen Zhang, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2536-2556.e30
Open Access | Times Cited: 20
Advances in high‐throughput mass spectrometry in drug discovery
María Emilia Dueñas, Rachel E. Heap, Melanie Leveridge, et al.
EMBO Molecular Medicine (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 61
Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
Fangjiao Huang, Xiaoli Han, Xiaohui Xiao, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7728-7728
Open Access | Times Cited: 58
The Growing Importance of Chirality in 3D Chemical Space Exploration and Modern Drug Discovery Approaches for Hit-ID
Ilaria Proietti Silvestri, Paul Colbon
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 8, pp. 1220-1229
Open Access | Times Cited: 57
Assigning functionality to cysteines by base editing of cancer dependency genes
Haoxin Li, Tiantai Ma, Jarrett R. Remsberg, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 11, pp. 1320-1330
Open Access | Times Cited: 39
E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology
Iacovos N. Michaelides, Gavin W. Collie
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3173-3194
Open Access | Times Cited: 26
Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments
Arron Aatkar, Aini Vuorinen, Oliver Longfield, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 9, pp. 1926-1937
Open Access | Times Cited: 23
Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders
Zhonglin Liu, Jarrett R. Remsberg, Haoxin Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 15, pp. 10393-10406
Closed Access | Times Cited: 14
Target Discovery Driven by Chemical Biology and Computational Biology
B J Lyu, Wenfeng Gou, Feifei Xu, et al.
The Chemical Record (2025)
Closed Access | Times Cited: 1
Recent progress in covalent warheads for in vivo targeting of endogenous proteins
Naoya Shindo, Akio Ojida
Bioorganic & Medicinal Chemistry (2021) Vol. 47, pp. 116386-116386
Open Access | Times Cited: 43
High-Throughput Native Mass Spectrometry Screening in Drug Discovery
Agni F. M. Gavriilidou, Kleitos Sokratous, Hsin‐Yung Yen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 37
Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
Haixiang Pei, Weikai Guo, Yangrui Peng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1607-1660
Closed Access | Times Cited: 30
Chemical tools to expand the ligandable proteome: diversity-oriented synthesis-based photoreactive stereoprobes
Daisuke Ogasawara, David B. Konrad, Zher Yin Tan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Machine Learning Models to Interrogate Proteome-Wide Covalent Ligandabilities Directed at Cysteines
Ruibin Liu, Joseph Clayton, Mingzhe Shen, et al.
JACS Au (2024) Vol. 4, Iss. 4, pp. 1374-1384
Open Access | Times Cited: 6
Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Closed Access | Times Cited: 6
CovPDB: a high-resolution coverage of the covalent protein–ligand interactome
Mingjie Gao, Aurélien F. A. Moumbock, Ammar Qaseem, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D445-D450
Open Access | Times Cited: 35
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
Angel Gonzalez-Valero, Audrey G. Reeves, Annika C. S. Page, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 50, pp. 22890-22901
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top